Atlas Trials

Sequencing-based Counting of Plasma Epstein-Barr Virus DNA in Non-metastatic Nasopharyngeal Carcinoma

Clinical trial NCT06321939 · RECRUITING

Trial details

NCT number
NCT06321939
Sponsor
Hunan Cancer Hospital
Status
RECRUITING
Study type
OBSERVATIONAL
Nasopharyngeal CarcinomaHerpesvirus 4, Human
Start date
2024-01-11
Primary completion
2026-12-31
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.